ARVN, NasdaqGS
Arvinas, Inc. (ARVN)
Price (as of October 25)
42.58USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Compass Therapeutics, Inc. |
-0.42 |
|
Chemomab Therapeutics Ltd. |
-0.35 |
|
CureVac N.V. |
-0.32 |
|
Genprex, Inc. |
-0.26 |
|
Akouos, Inc. |
-0.24 |
|
Daré Bioscience, Inc. |
-0.05 |
|
Applied Therapeutics, Inc. |
-0.04 |
|
Caribou Biosciences, Inc. |
-0.03 |
|
Anixa Biosciences, Inc. |
-0.07 |
|
CEL-SCI Corporation |
-0.01 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.85 |
|
Arcturus Therapeutics Holdings Inc. |
0.76 |
|
Atai Life Sciences N.V. |
0.75 |
|
Atara Biotherapeutics, Inc. |
0.74 |
|
Ardelyx, Inc. |
0.7 |
|
Ascendis Pharma A/S |
0.23 |
|
argenx SE |
0.28 |
|
Artelo Biosciences, Inc. |
0.09 |
|
Assembly Biosciences, Inc. |
0.14 |
|
Allogene Therapeutics, Inc. |
0.29 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Akouos, Inc. |
-0.16 |
|
Arcellx, Inc. |
-0.13 |
|
Chemomab Therapeutics Ltd. |
-0.11 |
|
Achieve Life Sciences, Inc. |
-0.1 |
|
Beam Therapeutics Inc. |
-0.09 |
|
Diffusion Pharmaceuticals Inc. |
-0.01 |
|
Acurx Pharmaceuticals, Inc. |
-0.05 |
|
ImmuCell Corporation |
-0.03 |
|
AgeX Therapeutics, Inc. |
-0.06 |
|
HOOKIPA Pharma Inc. |
-0.04 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.63 |
|
Allogene Therapeutics, Inc. |
0.57 |
|
Atara Biotherapeutics, Inc. |
0.51 |
|
ALX Oncology Holdings Inc. |
0.49 |
|
Arcturus Therapeutics Holdings Inc. |
0.49 |
|
argenx SE |
0.28 |
|
Alpine Immune Sciences, Inc. |
0.13 |
|
AnaptysBio, Inc. |
0.13 |
|
Arcutis Biotherapeutics, Inc. |
0.27 |
|
AlloVir, Inc. |
0.3 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.13 |
|
Akouos, Inc. |
-0.11 |
|
CureVac N.V. |
-0.11 |
|
Akero Therapeutics, Inc. |
-0.1 |
|
Cue Biopharma, Inc. |
-0.09 |
|
Aadi Bioscience, Inc. |
-0.08 |
|
Beam Therapeutics Inc. |
-0.08 |
|
Anixa Biosciences, Inc. |
-0.07 |
|
Gain Therapeutics, Inc. |
-0.06 |
|
AIkido Pharma Inc. |
-0.06 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.38 |
|
Arrowhead Pharmaceuticals, Inc. |
0.37 |
|
Atara Biotherapeutics, Inc. |
0.31 |
|
AlloVir, Inc. |
0.3 |
|
Allogene Therapeutics, Inc. |
0.29 |
|
Alnylam Pharmaceuticals, Inc. |
0.29 |
|
argenx SE |
0.28 |
|
ALX Oncology Holdings Inc. |
0.28 |
|
Arcutis Biotherapeutics, Inc. |
0.27 |
|
Amylyx Pharmaceuticals, Inc. |
0.25 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.13 |
|
Akouos, Inc. |
-0.11 |
|
CureVac N.V. |
-0.11 |
|
Akero Therapeutics, Inc. |
-0.1 |
|
Cue Biopharma, Inc. |
-0.09 |
|
Aadi Bioscience, Inc. |
-0.08 |
|
Beam Therapeutics Inc. |
-0.08 |
|
Anixa Biosciences, Inc. |
-0.07 |
|
Gain Therapeutics, Inc. |
-0.06 |
|
AIkido Pharma Inc. |
-0.06 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.38 |
|
Arrowhead Pharmaceuticals, Inc. |
0.37 |
|
Atara Biotherapeutics, Inc. |
0.31 |
|
AlloVir, Inc. |
0.3 |
|
Allogene Therapeutics, Inc. |
0.29 |
|
Alnylam Pharmaceuticals, Inc. |
0.29 |
|
argenx SE |
0.28 |
|
ALX Oncology Holdings Inc. |
0.28 |
|
Arcutis Biotherapeutics, Inc. |
0.27 |
|
Amylyx Pharmaceuticals, Inc. |
0.25 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Compass Therapeutics, Inc. |
-0.42 |
|
Chemomab Therapeutics Ltd. |
-0.35 |
|
CureVac N.V. |
-0.32 |
|
Genprex, Inc. |
-0.26 |
|
Dynavax Technologies Corporation |
-0.26 |
|
Glaukos Corporation |
-0.05 |
|
Field Trip Health Ltd. |
-0 |
|
Cardiol Therapeutics Inc. |
-0.07 |
|
Akouos, Inc. |
-0.11 |
|
Clever Leaves Holdings Inc. |
-0.05 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.85 |
|
Arcturus Therapeutics Holdings Inc. |
0.76 |
|
Atai Life Sciences N.V. |
0.75 |
|
Atara Biotherapeutics, Inc. |
0.74 |
|
Ardelyx, Inc. |
0.7 |
|
Ascendis Pharma A/S |
0.23 |
|
Accuray Incorporated |
0.3 |
|
Alphatec Holdings, Inc. |
0.22 |
|
Aquestive Therapeutics, Inc. |
0.24 |
|
argenx SE |
0.28 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Akouos, Inc. |
-0.16 |
|
Grifols, S.A. |
-0.13 |
|
Arcellx, Inc. |
-0.13 |
|
Cardiol Therapeutics Inc. |
-0.12 |
|
AmerisourceBergen Corporation |
-0.12 |
|
Acutus Medical, Inc. |
-0.05 |
|
Chemomab Therapeutics Ltd. |
0 |
|
Convey Health Solutions Holdings, Inc. |
-0.11 |
|
Glaukos Corporation |
-0.05 |
|
Akanda Corp. |
-0.1 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.63 |
|
Allogene Therapeutics, Inc. |
0.57 |
|
Atara Biotherapeutics, Inc. |
0.51 |
|
ALX Oncology Holdings Inc. |
0.49 |
|
Arcturus Therapeutics Holdings Inc. |
0.49 |
|
Accuray Incorporated |
0.3 |
|
Apollo Medical Holdings, Inc. |
0.27 |
|
American Well Corporation |
0.25 |
|
argenx SE |
0.28 |
|
Alpine Immune Sciences, Inc. |
0.13 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.13 |
|
Akouos, Inc. |
-0.11 |
|
Convey Health Solutions Holdings, Inc. |
-0.11 |
|
CureVac N.V. |
-0.11 |
|
Akanda Corp. |
-0.1 |
|
Akero Therapeutics, Inc. |
-0.1 |
|
AmerisourceBergen Corporation |
-0.1 |
|
Cue Biopharma, Inc. |
-0.09 |
|
CVS Health Corporation |
-0.08 |
|
Aadi Bioscience, Inc. |
-0.08 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.38 |
|
Arrowhead Pharmaceuticals, Inc. |
0.37 |
|
Atara Biotherapeutics, Inc. |
0.31 |
|
AlloVir, Inc. |
0.3 |
|
Accuray Incorporated |
0.3 |
|
Allogene Therapeutics, Inc. |
0.29 |
|
Alnylam Pharmaceuticals, Inc. |
0.29 |
|
argenx SE |
0.28 |
|
Amneal Pharmaceuticals, Inc. |
0.28 |
|
ALX Oncology Holdings Inc. |
0.28 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.13 |
|
Akouos, Inc. |
-0.11 |
|
Convey Health Solutions Holdings, Inc. |
-0.11 |
|
CureVac N.V. |
-0.11 |
|
Akanda Corp. |
-0.1 |
|
Akero Therapeutics, Inc. |
-0.1 |
|
AmerisourceBergen Corporation |
-0.1 |
|
Cue Biopharma, Inc. |
-0.09 |
|
CVS Health Corporation |
-0.08 |
|
Aadi Bioscience, Inc. |
-0.08 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.38 |
|
Arrowhead Pharmaceuticals, Inc. |
0.37 |
|
Atara Biotherapeutics, Inc. |
0.31 |
|
AlloVir, Inc. |
0.3 |
|
Accuray Incorporated |
0.3 |
|
Allogene Therapeutics, Inc. |
0.29 |
|
Alnylam Pharmaceuticals, Inc. |
0.29 |
|
argenx SE |
0.28 |
|
Amneal Pharmaceuticals, Inc. |
0.28 |
|
ALX Oncology Holdings Inc. |
0.28 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
FutureTech II Acquisition Corp. |
-0.46 |
|
Compass Therapeutics, Inc. |
-0.42 |
|
First Reserve Sustainable Growth Corp. |
-0.36 |
|
Canadian Solar Inc. |
-0.36 |
|
Chemomab Therapeutics Ltd. |
-0.35 |
|
ADTRAN Holdings, Inc. |
-0.04 |
|
Cohu, Inc. |
-0.05 |
|
CureVac N.V. |
-0.11 |
|
Dingdong (Cayman) Limited |
-0.09 |
|
AirNet Technology Inc. |
-0.03 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Genomic Revolution ETF |
0.86 |
|
Arrowhead Pharmaceuticals, Inc. |
0.85 |
|
ARK Autonomous Technology & Robotics ETF |
0.8 |
|
ARK Space Exploration & Innovation ETF |
0.79 |
|
Arrival |
0.77 |
|
Arcturus Therapeutics Holdings Inc. |
0.18 |
|
Atai Life Sciences N.V. |
0.38 |
|
Atara Biotherapeutics, Inc. |
0.31 |
|
AI Quality Growth ETF |
0.57 |
|
Ardelyx, Inc. |
0.11 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
FutureTech II Acquisition Corp. |
-0.38 |
|
Excelerate Energy, Inc. |
-0.25 |
|
Forafric Global PLC |
-0.23 |
|
Genius Group Limited |
-0.22 |
|
Dimensional International Core Equity 2 ETF |
-0.22 |
|
Gores Holdings IX, Inc. |
-0.21 |
|
Claros Mortgage Trust, Inc. |
-0.2 |
|
Optica Rare Earths & Critical Materials ETF |
-0.2 |
|
Dimensional US Small Cap Value ETF |
-0.18 |
|
Dakota Gold Corp. |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Genomic Revolution ETF |
0.67 |
|
Arrowhead Pharmaceuticals, Inc. |
0.63 |
|
ARK Autonomous Technology & Robotics ETF |
0.58 |
|
ARK Space Exploration & Innovation ETF |
0.58 |
|
Ares Management Corporation |
0.58 |
|
AI Quality Growth ETF |
0.57 |
|
Allogene Therapeutics, Inc. |
0.29 |
|
Alarm.com Holdings, Inc. |
0.27 |
|
Atara Biotherapeutics, Inc. |
0.31 |
|
Altair Engineering Inc. |
0.31 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
FutureTech II Acquisition Corp. |
-0.38 |
|
Excelerate Energy, Inc. |
-0.25 |
|
Forafric Global PLC |
-0.23 |
|
Genius Group Limited |
-0.22 |
|
Dimensional International Core Equity 2 ETF |
-0.22 |
|
Gores Holdings IX, Inc. |
-0.21 |
|
Claros Mortgage Trust, Inc. |
-0.2 |
|
Optica Rare Earths & Critical Materials ETF |
-0.2 |
|
Dimensional US Small Cap Value ETF |
-0.18 |
|
Dakota Gold Corp. |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
AI Quality Growth ETF |
0.57 |
|
ARK Space Exploration & Innovation ETF |
0.55 |
|
Argo Blockchain plc |
0.46 |
|
ARK Genomic Revolution ETF |
0.46 |
|
Alkami Technology, Inc. |
0.39 |
|
ARK Autonomous Technology & Robotics ETF |
0.38 |
|
GLOBAL X CLEAN WATER ETF |
0.38 |
|
Atai Life Sciences N.V. |
0.38 |
|
Arrowhead Pharmaceuticals, Inc. |
0.37 |
|
Ares Management Corporation |
0.36 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
FutureTech II Acquisition Corp. |
-0.38 |
|
Excelerate Energy, Inc. |
-0.25 |
|
Forafric Global PLC |
-0.23 |
|
Genius Group Limited |
-0.22 |
|
Dimensional International Core Equity 2 ETF |
-0.22 |
|
Gores Holdings IX, Inc. |
-0.21 |
|
Claros Mortgage Trust, Inc. |
-0.2 |
|
Optica Rare Earths & Critical Materials ETF |
-0.2 |
|
Dimensional US Small Cap Value ETF |
-0.18 |
|
Dakota Gold Corp. |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
AI Quality Growth ETF |
0.57 |
|
ARK Space Exploration & Innovation ETF |
0.55 |
|
Argo Blockchain plc |
0.46 |
|
ARK Genomic Revolution ETF |
0.46 |
|
Alkami Technology, Inc. |
0.39 |
|
ARK Autonomous Technology & Robotics ETF |
0.38 |
|
GLOBAL X CLEAN WATER ETF |
0.38 |
|
Atai Life Sciences N.V. |
0.38 |
|
Arrowhead Pharmaceuticals, Inc. |
0.37 |
|
Ares Management Corporation |
0.36 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.